PRIGX
Price
$24.42
Change
+$0.22 (+0.91%)
Updated
Jun 18 closing price
Net Assets
300.36M
TEDRX
Price
$30.32
Change
-$0.01 (-0.03%)
Updated
Jun 18 closing price
Net Assets
8.99B
Interact to see
Advertisement

PRIGX vs TEDRX

PRIGX vs TEDRX Comparison Chart in %
View a ticker or compare two or three
VS
PRIGX vs. TEDRX commentary
Jun 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRIGX is a Hold and TEDRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TEDRX has more cash in the bank: 8.99B vs. PRIGX (300M). PRIGX pays higher dividends than TEDRX: PRIGX (1.91) vs TEDRX (1.40). PRIGX was incepted earlier than TEDRX: PRIGX (14 years) vs TEDRX (24 years). TEDRX (1.45) is less costly to investors than PRIGX (0.89). PRIGX is a more actively managed with annual turnover of: 76.90 vs. TEDRX (42.28). TEDRX has a lower initial minimum investment than PRIGX: TEDRX (1000) vs PRIGX (500000). PRIGX annual gain was more profitable for investors over the last year : 35.95 vs. TEDRX (2.10). PRIGX return over 5 years is better than : 66.09 vs. TEDRX (2.34).
PRIGXTEDRXPRIGX / TEDRX
Total Expense Ratio0.681.4547%
Annual Report Gross Expense Ratio0.891.4561%
Fund Existence14 years24 years-
Gain YTD17.9710.2656,793%
Front LoadN/AN/A-
Min. Initial Investment500000100050,000%
Min. Initial Investment IRAN/AN/A-
Net Assets300M8.99B3%
Annual Yield % from dividends1.911.40136%
Returns for 1 year35.952.101,711%
Returns for 3 years63.417.51845%
Returns for 5 years66.092.342,830%
Returns for 10 years150.0515.36977%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBMOX61.281.67
+2.80%
Neuberger Small Cap Growth Tr
RYMDX167.492.68
+1.63%
Rydex Mid-Cap 1.5x Strategy H
FZALX34.170.34
+1.01%
Fidelity Advisor Mega Cap Stock Z
HMCRX18.010.12
+0.67%
Harbor Mid Cap Retirement
FBTCX30.490.01
+0.03%
Fidelity Advisor Biotechnology C